“Breaking Boundaries: MedMira’s Multiplor TPHIV Self-Test Receives Investigational Testing Authorizations for Non-Professional Use in Healthcare and Pharmaceutical Industry”
Exciting News for MedMira Inc. as Health Canada Approves Clinical Trials for New Label Claims Journey to Expanded Access to Testing for Syphilis and HIV in Canada Halifax, NS / Access Newswire / January 21, 2025 – MedMira Inc. (MedMira) (TSXV:MIR) has recently received Investigational Testing Authorizations (ITAs) from Health Canada to commence clinical trials…